SANTHERA PHARMACEUTICALS HOLDING AG CHF0.1 (POST CONS) earnings per share and revenue

Company revenue for the same period amounts to 14.10 M CHF despite the estimated figure of 5.60 M CHF. Also watch annual changes over time to get a bigger picture of 0QN1 earnings per share and revenue dynamics.